Fentanyl, Inc.
how rogue chemists are creating the deadliest wave of the opioid epidemic
Seiten
2019
Scribe Publications (Verlag)
978-1-912854-51-6 (ISBN)
Scribe Publications (Verlag)
978-1-912854-51-6 (ISBN)
A TELEGRAPH BOOK OF THE YEAR.
An undercover investigation into the synthetic-drug epidemic.
A new group of chemicals is radically transforming the recreational-drug landscape. Known as novel psychoactive substances (NPS), they range from so-called ‘legal highs’ like Spice, to synthetic opioids – most famously, the deadly fentanyl.
Designed to replicate the effects of established drugs like cocaine, ecstasy, marijuana, and heroin, NPS are synthesised in laboratories. They are cheap to produce and easy to transport. They are also extremely potent and often deadly. Originally developed for medicinal purposes, and then hijacked by rogue chemists, who change their molecular structures to stay ahead of the law, these chemicals’ effects can be impossible to predict. What we do know is that they have triggered the biggest drug epidemic that America has ever seen, and which is now spreading internationally.
In Fentanyl, Inc., award-winning journalist Ben Westhoff goes undercover to investigate the shadowy world of synthetic drugs — becoming, in the process, the first journalist to infiltrate a Chinese fentanyl lab. He tracks down the drug baron in New Zealand who unintentionally helped to start the synthetic-drug revolution; prowls St. Louis streets with a former fentanyl dealer to understand how the epidemic started; and chronicles the lives of addicts and dealers, families of victims, law enforcement officers, and underground drug-awareness organisers in the US and Europe. Fentanyl, Inc. is essential reading on a global calamity we are only just beginning to understand.
An undercover investigation into the synthetic-drug epidemic.
A new group of chemicals is radically transforming the recreational-drug landscape. Known as novel psychoactive substances (NPS), they range from so-called ‘legal highs’ like Spice, to synthetic opioids – most famously, the deadly fentanyl.
Designed to replicate the effects of established drugs like cocaine, ecstasy, marijuana, and heroin, NPS are synthesised in laboratories. They are cheap to produce and easy to transport. They are also extremely potent and often deadly. Originally developed for medicinal purposes, and then hijacked by rogue chemists, who change their molecular structures to stay ahead of the law, these chemicals’ effects can be impossible to predict. What we do know is that they have triggered the biggest drug epidemic that America has ever seen, and which is now spreading internationally.
In Fentanyl, Inc., award-winning journalist Ben Westhoff goes undercover to investigate the shadowy world of synthetic drugs — becoming, in the process, the first journalist to infiltrate a Chinese fentanyl lab. He tracks down the drug baron in New Zealand who unintentionally helped to start the synthetic-drug revolution; prowls St. Louis streets with a former fentanyl dealer to understand how the epidemic started; and chronicles the lives of addicts and dealers, families of victims, law enforcement officers, and underground drug-awareness organisers in the US and Europe. Fentanyl, Inc. is essential reading on a global calamity we are only just beginning to understand.
Ben Westhoff is an award-winning investigative reporter who has covered stories ranging from gangland Los Angeles to Native American blood feuds to government corruption. He has written at length about music and culture, his entry point to the world of synthetic drugs, in Rolling Stone, The Guardian, Village Voice, Vice, Oxford American, the Wall Street Journal, and elsewhere. He is the author of two previous books: Original Gangstas: The Untold Story of Dr. Dre, Eazy-E, Ice Cube, Tupac Shakur, and the Birth of West Coast Rap (Hachette, 2016), and Dirty South: Outkast, Lil Wayne, Soulja Boy, and the Southern Rappers Who Reinvented Hip-Hop (Chicago Review Press, 2011).
| Erscheinungsdatum | 03.10.2019 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Maße | 153 x 234 mm |
| Gewicht | 465 g |
| Einbandart | Paperback |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| Sozialwissenschaften ► Soziologie | |
| ISBN-10 | 1-912854-51-1 / 1912854511 |
| ISBN-13 | 978-1-912854-51-6 / 9781912854516 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 33,55
Menschen mit psychischer Erkrankung wirksam unterstützen
Buch | Hardcover (2023)
Psychiatrie Verlag
CHF 48,95
